2 Dividend Stocks To Fuel Growth In Your Retirement Income

 | Oct 13, 2022 17:59

  • This year's bear market could represent an attractive long-term opportunity for those looking to start building a retirement portfolio
  • Medtronic is a lesser-known pick, but with solid growth potential and chunky yields
  • Lowe's remains a dividend favorite, despite growing risks in the housing market
  • The best time to start building your retirement portfolio is when you’re young, have disposable income to spare, and when asset prices are down. So if you’re embarking on this journey just now, time is definitely on your side.

    Since the start of this year, the persistent sell-off has pushed major indices into bear markets, making many stocks attractive for long-term, buy-and-hold investors.

    There are many ways to benefit from this downturn. You can buy some top growth companies which command a defendable “economic moat,” a term coined by Warren Buffett to identify quality stocks with a vast competitive advantage.

    If your ultimate goal is to generate consistent income through this portfolio, then another option is to buy dividend stocks that provide income through regular payouts.

    A quality dividend stock is less likely to slash or suspend its dividend payments during market volatility, making it much easier to hold in your portfolio over the long run. Once you buy such assets, you keep them over the long run and focus on their income-generating capabilities.

    With these factors in mind, below I’ve short-listed two large-cap dividend stocks that might suit your retirement goals in this bear market:

    h2 1. Medtronic/h2

    Healthcare stocks are considered relatively safe. Just like retailers, utilities, and garbage collectors, healthcare providers offer services that remain necessary even during a recession. Plus, economic swings don’t typically curb the roll-out of new drugs and devices.

    Medtronic (NYSE:MDT) is a lesser-known healthcare stock that I recommend to long-term investors due to its strong market position and hefty payouts. The world’s biggest medical device maker controls 50% of the global pacemaker market. It’s also a product leader assisting spinal surgeries and diabetes care.